152 related articles for article (PubMed ID: 29529089)
1. RAGE-specific single chain Fv for PET imaging of pancreatic cancer.
Kim HY; Wang X; Kang R; Tang D; Boone BA; Zeh HJ; Lotze MT; Edwards WB
PLoS One; 2018; 13(3):e0192821. PubMed ID: 29529089
[TBL] [Abstract][Full Text] [Related]
2. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28.
Lanfranca MP; Lazarus J; Shao X; Nathan H; Di Magliano MP; Zou W; Piert M; Frankel TL
J Surg Res; 2018 Dec; 232():570-577. PubMed ID: 30463776
[TBL] [Abstract][Full Text] [Related]
3. A Novel Approach for Image-Guided
Schug C; Gupta A; Urnauer S; Steiger K; Cheung PF; Neander C; Savvatakis K; Schmohl KA; Trajkovic-Arsic M; Schwenk N; Schwaiger M; Nelson PJ; Siveke JT; Spitzweg C
Mol Cancer Res; 2019 Jan; 17(1):310-320. PubMed ID: 30224540
[TBL] [Abstract][Full Text] [Related]
4. RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer.
Azizan N; Suter MA; Liu Y; Logsdon CD
Biochem Biophys Res Commun; 2017 Nov; 493(1):592-597. PubMed ID: 28867179
[TBL] [Abstract][Full Text] [Related]
5. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of
Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
[TBL] [Abstract][Full Text] [Related]
7. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
8. Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma.
Uchida C; Mizukami H; Hara Y; Saito T; Umetsu S; Igawa A; Osonoi S; Kudoh K; Yamamoto Y; Yamamoto H; Yagihashi S; Hakamada K
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769147
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma.
Kong Y; Xie F; Zhang Z; Wang S; Zhang Y; Di Y; Zhou Z; Jiang D; Li J; Huang Q; Wang J; Li X; Pan Z; Ni R; Guan Y
Eur Radiol; 2023 Oct; 33(10):7077-7088. PubMed ID: 37166496
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME)
Nabavizadeh A; Payen T; Iuga AC; Sagalovskiy IR; Desrouilleres D; Saharkhiz N; Palermo CF; Sastra SA; Oberstein PE; Rosario V; Kluger MD; Schrope BA; Chabot JA; Olive KP; Konofagou EE
Theranostics; 2020; 10(10):4614-4626. PubMed ID: 32292518
[No Abstract] [Full Text] [Related]
11. Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Abou-Elkacem L; Wang H; Chowdhury SM; Kimura RH; Bachawal SV; Gambhir SS; Tian L; Willmann JK
Clin Cancer Res; 2018 Apr; 24(7):1574-1585. PubMed ID: 29301827
[No Abstract] [Full Text] [Related]
12. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
13. Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer.
Sun L; Gai Y; Li Z; Li H; Li J; Muschler J; Kang R; Tang D; Zeng D
Mol Imaging Biol; 2022 Aug; 24(4):580-589. PubMed ID: 35229260
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a
Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
[TBL] [Abstract][Full Text] [Related]
15. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice.
Johnson BL; d'Alincourt Salazar M; Mackenzie-Dyck S; D'Apuzzo M; Shih HP; Manuel ER; Diamond DJ
PLoS One; 2019; 14(9):e0221810. PubMed ID: 31490946
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
Vernon PJ; Loux TJ; Schapiro NE; Kang R; Muthuswamy R; Kalinski P; Tang D; Lotze MT; Zeh HJ
J Immunol; 2013 Feb; 190(3):1372-9. PubMed ID: 23269246
[TBL] [Abstract][Full Text] [Related]
18. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
19. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma.
Bam R; Daryaei I; Abou-Elkacem L; Vilches-Moure JG; Meuillet EJ; Lutz A; Marinelli ER; Unger EC; Gambhir SS; Paulmurugan R
Invest Radiol; 2020 Nov; 55(11):711-721. PubMed ID: 32569010
[TBL] [Abstract][Full Text] [Related]
20. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
